XML 138 R107.htm IDEA: XBRL DOCUMENT v3.25.4
Share-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2018
Mar. 31, 2025
Jun. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Feb. 20, 2026
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense       $ 54,553 $ 48,613 $ 51,137  
Granted (in shares)           0  
Cash received from stock options exercised         0 $ 0  
Intrinsic value of options exercised       6,000 0 0  
Modified Awards              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense   $ 11,000 $ 13,000        
Share-based Payment Arrangement, Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense       17,000 $ 11,000 1,000  
Cash received from stock options exercised       19,000      
Nonvested award, cost not yet recognized, amount       $ 8,000      
Restricted Stock Units (RSUs) | Origin AI | Subsequent Event              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common stock, number of shares authorized (in shares)             8,100,000
Share-Based Compensation, 2016 Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common stock, number of shares authorized (in shares)       5,000,000      
Class B Units | Restricted Stock              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Conversion of stock, issued (in shares)       20,600,000      
Common stock, service award vesting conditions, percentage       50.00%      
Common stock, award requisite service period       5 years      
Class B units stock, percent with performance award vesting conditions       50.00%      
Class B Units | Restricted Stock, Performance Tranche              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Number of distributed shares (in shares)       3,600,000      
Share-based Compensation, 2018 Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Common stock, number of shares authorized (in shares)       138,000,000      
Common stock, award requisite service period 12 months            
Share-based Compensation, 2018 Plan | Share-based Payment Arrangement, Top-up Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares) 12,700,000            
Share-based compensation arrangement by share-based payment award, contractual terms of award 10 years            
Initial public offering, vested period 6 months            
Share-based Compensation, 2018 Plan | Share-based Payment Arrangement, Option              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Granted (in shares)       8,662,363      
Class B units stock, terms of award 3 years            
Share-based compensation arrangement by share-based payment award, award grant period 10 years            
Share-based compensation arrangement by Share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share)       $ 2.66 $ 2.56    
Share-based Compensation, 2018 Plan | Restricted Stock Units (RSUs)              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Total share-based compensation expense       $ 27,000 $ 25,000 $ 47,000  
Common stock, award requisite service period       3 years      
Number of distributed shares (in shares)       7,981,940 8,264,015    
Nonvested award, cost not yet recognized, amount       $ 25,000      
Granted (in dollars per share)       $ 7.69 $ 6.65 $ 7.56  
Share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value       $ 33,000 $ 34,000 $ 56,000  
Stock options, nonvested award, cost not yet recognized, period for recognition       1 year 8 months 12 days